GE HealthCare Technologies
- Market cap
- 29.21B
- P/E (TTM)i
- 14.90
- P/Bi
- 2.66
- EPSi
- 4.55
- Div yieldi
- 0.22%
- 52W posi
- 19%
Anonymous reader poll. Unscientific, not investment advice.
About GE HealthCare Technologies
GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. It operates through the following segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment provides scanning devices, clinical applications, service capabilities, and digital solutions. The AVS segment offers screening, diagnosis, treatment, and monitoring of certain diseases. The PCS segment specializes in providing medical devices, consumables, services, and digital solutions. The PDx segment supplies diagnostic agents to the global radiology and nuclear medicine community. The company was founded in 1892. It was incorporated on May 16, 2022 and is headquartered in Chicago, IL.
- Founded
- 1892
- CEO
- Mr. Peter J. Arduini
- Employees
- 54,000
- Headquarters
- Chicago, Illinois, United States of America
- Fiscal year end
- 12-31
- Website
- gehealthcare.com
Company profile
- Exchange
- US
- Symbol
- GEHC
- Market-cap rank
- #689
- Listing date
- 2022-12-15
- Market cap
- 29.21B
- Float cap
- 29.11B
- Shares out
- 451.69M
- Float shares
- 450.19M
Sectors & themes
Quote time 2026-10-08 06:39:23 · For reference only, not investment advice and not tailored to your situation.